Table 2 Results of QuantiFERON-TB Gold In-Tube (QFT) among study populations by age and gender.
Total | 15–19 years | 20–29 years | 30–39 years | ≥40 years | p | |
|---|---|---|---|---|---|---|
Total | ||||||
Negative | 3611 (81.66) | 261 (95.26) | 2111 (87.20) | 825 (77.46) | 414 (63.50) | <0.001 |
Positive | 790 (17.87) | 13 (4.74) | 310 (12.75) | 237 (22.25) | 230 (35.28) | |
Indeterminate | 21 (0.47) | 0 | 10 (0.41) | 3 (0.28) | 8 (1.23) | |
Male | ||||||
Negative | 2158 (80.70) | 132 (94.29) | 1287 (86.49) | 519 (77.12) | 220 (58.98) | <0.001 |
Positive | 509 (19.04) | 8 (5.71) | 198 (13.31) | 154 (22.88) | 149 (39.95) | |
Indeterminate | 7 (0.26) | 0 | 3 (0.20) | 0 | 4 (1.07) | |
Female | ||||||
Negative | 1453 (83.12) | 129 (96.27) | 824 (87.38) | 306 (79.06) | 194 (69.53) | <0.001 |
Positive | 281 (16.08) | 5 (3.73) | 112 (11.88) | 83 (21.17) | 81 (29.03) | |
Indeterminate | 14 (0.80) | 0 | 7 (0.74) | 3 (0.77) | 4 (1.43) | |
